Items tagged with Advocacy
Mid-campaign report highlights what’s needed to win better, shorter TB treatments for all by end of 2024 (post with simple image)
With less than a year to go until the 1/4/6x24 Campaign deadline, the Getting Better Faster: Delivering on the Promise of New TB Treatments report outlines both progress made and remaining gaps toward achieving 1/4/6x24.
Three wins needed to deliver new TB vaccines this decade (post with simple image)
The TB Vax ARM outlines three key advocacy wins for the field to achieve by 2026 in order to effectively advance TB vaccine development. Check them out and sign a petition to show your support!
Stigma kills: Why medicine alone won’t end TB (post with simple image)
Results UK’s new advocacy report presents the case for adopting a whole of society approach to ending TB, focused on addressing the underlying social causes of TB alongside curing the physical disease.
WHO: World TB Day newsletter (post with simple image)
On World TB Day, WHO is calling for action on several fronts to ensure that the commitments made to end TB are achieved. A special newsletter edition compiles all WHO advocacy activities and key resources released in the lead-up to World TB Day.
MSF publishes cost of its TB clinical trial (post with simple image)
Transparency on clinical trial costs must become the norm to improve access to medical products worldwide.
Community statement: Introduction of child-friendly formulation of rifapentine for short-course TB preventive treatment (post with simple image)
Safeguarding children against TB takes center stage with introduction of child-friendly formulation of rifapentine for short-course TB preventive treatment.
An Activist’s Guide to Rifapentine TB Preventive Treatment: 3HP and 1HP (post with simple image)
The new 2024 update of An Activist’s Guide to Rifapentine TB Preventive Treatment: 3HP and 1HP lays out what TB community advocates need to know about rifapentine-based TB preventive treatment.
Page 124 of 124 · Total posts: 0
←First 123 124